Login / Signup

Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation.

Kyle D StallerKenneth BarshopA N AnanthakrishnanB Kuo
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2017)
Among patients with chronic constipation, number of retained markers on a ROM colonic transit study does not correlate with measures of symptom severity or QOL. Clinicians should be cautious about overinterpreting ROM transit testing.
Keyphrases
  • ulcerative colitis